FDA Heralds The End Of Switching Studies For Biosimilar Interchangeability

Guidance Suggests Analytical And Clinical Data Can Be Sufficient To Support Application

 
• By David Wallace
  
Red on off switch
The FDA is switching off the requirement for switching studies • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products